معرفی
Chad Binns is an Instructor of Laboratory Medicine at Yale School of Medicine specializing in transfusion medicine with research interests at the intersection of pharmacology and immunohematology. His work focuses on applying nanoparticle technology to transfusion medicine contexts and studying how blood product formulation correlates with patient outcomes.
Dr. Binns' educational background includes:
- BA in Biology from Hendrix College (2013), where he studied miRNA therapeutics in prostate cancer models
- MD from University of Arkansas for Medical Sciences (2019)
- HHMI-funded Medical Research Fellowship at Janelia Research Campus (2018), developing novel photosensitizers
- Residency at Yale New Haven Hospital (2022)
- Transfusion Medicine Fellowship at Yale University (2023)
Dr. Binns' research bridges multiple disciplines with a primary focus on how nanoparticle drug delivery systems can be applied in transfusion medicine. He investigates cellular determinants of red blood cell interactions with polymeric nanoparticles, blood product formulation and modification, and their correlation with clinical outcomes. His work spans from basic science investigations of molecular tools to clinical applications in immunohematology and transfusion safety.
Analysis of Dr. Binns' publication record reveals a strong interdisciplinary approach connecting nanotechnology, pharmacology, and transfusion medicine. His research spans both fundamental investigations of nanoparticle-blood interactions and clinical studies examining adverse events, therapeutic applications, and blood product safety. The work demonstrates progression from basic molecular tool development to clinical applications, with increasing focus on patient outcomes and translational research.
Dr. Binns maintains active clinical research collaborations with multiple colleagues at Yale, including Nataliya Sostin, Christopher Tormey, Jeanne Hendrickson, Kristin Stendahl, Marie Egan, and W. Mark Saltzman. His collaborative approach spans laboratory investigations, clinical studies, and systematic reviews addressing challenges in transfusion medicine, immunohematology, and blood product safety.